Skip to content
TriangleGet started
← Full study record

NCT01558921 · OUTCOME

Quality of Life QLQ-C30 Scores

Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial · Source last updated 2026-05-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
score on a scale
Interval / dispersion
Standard Deviation
Time frame
3 year after surgery

What was measured

Quality of life QLQ-C30 core questionnaire EORTC quality-of-life instrument for use in international clinical trials in oncology A total Quality of Life Questionnaire (QLQ) score can range from 0 to 88, higher score means worse outcome.

Analysis population: 574 Patients without DrTF at 3 years post surgery were eligible to receive the questionnaires 495 questionnaires were returned, 453 analyzed (completed within time lines)

Groups in this outcome

Experimental Group

Experimental group B: 5x5Gy -\> CAPOX -\> Surgery

Standard of Care Group With Post-operative Chemotherapy

Standard of care group with post-operative chemotherapy Chemoradiation -\> surgery -\> CAPOX

Standard of Care Group Without Post-operative Chemotherapy

Standard of care group without post-operative chemotherapy Chemoradiation -\> surgery

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Experimental Group243
Standard of Care Group With Post-operative Chemotherapy99
Standard of Care Group Without Post-operative Chemotherapy111

Reported measurements

Source class 1
Values in score on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Experimental Group40.64.6Not reportedNot reportedNot reported
Standard of Care Group With Post-operative Chemotherapy41.24.8Not reportedNot reportedNot reported
Standard of Care Group Without Post-operative Chemotherapy40.14.1Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        4.6
        value
        40.6
      2. group Id
        OG001
        spread
        4.8
        value
        41.2
      3. group Id
        OG002
        spread
        4.1
        value
        40.1
denoms
  1. counts
    1. group Id
      OG000
      value
      243
    2. group Id
      OG001
      value
      99
    3. group Id
      OG002
      value
      111
    units
    Participants
description
Quality of life QLQ-C30 core questionnaire EORTC quality-of-life instrument for use in international clinical trials in oncology A total Quality of Life Questionnaire (QLQ) score can range from 0 to 88, higher score means worse outcome.
dispersion Type
Standard Deviation
groups
  1. description
    Experimental group B: 5x5Gy -\> CAPOX -\> Surgery
    id
    OG000
    title
    Experimental Group
  2. description
    Standard of care group with post-operative chemotherapy Chemoradiation -\> surgery -\> CAPOX
    id
    OG001
    title
    Standard of Care Group With Post-operative Chemotherapy
  3. description
    Standard of care group without post-operative chemotherapy Chemoradiation -\> surgery
    id
    OG002
    title
    Standard of Care Group Without Post-operative Chemotherapy
param Type
MEAN
population Description
574 Patients without DrTF at 3 years post surgery were eligible to receive the questionnaires 495 questionnaires were returned, 453 analyzed (completed within time lines)
reporting Status
POSTED
time Frame
3 year after surgery
title
Quality of Life QLQ-C30 Scores
type
SECONDARY
unit Of Measure
score on a scale

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Independent clinical review pending · Not medical advice